We just didn t want to wait. Parents enroll young children in vaccine trial
News 12 Staff
Updated on:May 05, 2021, 12:50pm EDT
A study of how Rockland-based Pfizer s vaccine affects very young children is underway.
News 12 spoke to one couple who enrolled their 8-month-old and 3-year-old sons into Pfizer s COVID-19 vaccine trial.
Already, 3-year-old Andel is fully vaccinated as of today. His 8-month-old brother Soren will receive his second dose next week. The brothers are enrolled in Stanford Medicine s Pfizer COVID vaccine trials for kids under 12. Aside from sore arms, they ve had no side effects.
Their parents say they made the decision to help ease fears others have about the vaccine and help everyone get one step closer to normal.
So worried : Indian community in Hudson Valley scared for family in India amid COVID-19 surge
News 12 Staff
Updated on:May 03, 2021, 5:47pm EDT
The coronavirus crisis is continuing to soar in India, hitting close to home for many in the Indian community in the Hudson Valley.
Itisha Bose of Scarsdale is scared for her family in India, which is dealing with the world s worst outbreak of coronavirus.
Her mother lives in the epicenter in the country s capital of New Delhi. I speak to my mother twice a day, because I m so worried, she said.
Hundreds of bodies are being burned daily and the hospitals are running out of oxygen.
FDA expected to approve Pfizer vaccine for children as young as 12 news12.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news12.com Daily Mail and Mail on Sunday newspapers.
CDC to study whether UK virus could be more deadly
News 12 Staff
Updated on:Jan 25, 2021, 3:37pm EST
There s new
concern today that the UK variant of COVID-19 not only spreads faster, but is
more deadly.
A UK report
released Friday states there is a realistic possibility that
variant is deadlier but states the data is not conclusive.
A recent
CDC model shows the new variant could become the predominant form of
coronavirus by March.
Experts say
the current vaccines should be effective against it.
The variant
has been found in 22 states and there have been 195 cases reported, but health
officials believe many more cases are going undetected.
Rockland-based Pfizer study suggests vaccine works against virus variant
Associated Press
Updated on:Jan 08, 2021, 5:30pm EST
New research suggests that Rockland County-based Pfizer’s COVID-19 vaccine can protect against a mutation found in two highly contagious variants of the coronavirus that erupted in Britain and South Africa.
Those variants are causing global concern. They both share a common mutation called N501Y, a slight alteration on one spot of the spike protein that coats the virus. That change is believed to be the reason they can spread so easily.
Most of the vaccines being rolled out around the world train the body to recognize that spike protein and fight it. Pfizer teamed with researchers from the University of Texas Medical Branch in Galveston for laboratory tests to see if the mutation affected its vaccine s ability to do so.